Search For "zycov d"
Zydus Cadila's COVID vaccines for children may be available in near future
Updated : 4 years, 10 months ago IST
New Delhi [India], July 16 (ANI): Pharmaceutical major Zydus Cadila's COVID-19 vaccine may be available in the near future for children in the age group of 12 to 18 years, the Centre in an affidavit told the Delhi High Court on Friday.
Read More
Emergency approval for Zydus Cadila to take few more days, say sources
Updated : 4 years, 10 months ago IST
New Delhi [India], July 12 (ANI): India's drug regulator Drugs Controller General of India (DCGI) will consider giving emergency use authorisation (EUA) to Zydus Cadila for its COVID-19 vaccine ZyCoV-D in a few more days, sources told ANI.
Read More
Zydus Cadila seeks nod for its COVID-19 vaccine ZyCoV-D, aims to produce 1
Updated : 4 years, 10 months ago IST
New Delhi [India], July 1 (ANI): The pharmaceutical firm Zydus Cadila on Thursday informed that it has applied for emergency use authorisation (EUA) from the Drug Controller General of India (DCGI) for its DNA vaccine ZyCoV-D against coronavirus disease and stated that they expect to produce
Read More
Zydus Cadila seeks emergency use authorisation for ZyCoV-D COVID-19 vaccin
Updated : 4 years, 10 months ago IST
New Delhi [India], July 1 (ANI): Pharmaceutical major Zydus Cadila on Thursday applied for Emergency Use Authorisation (EUA) seeking approval from the Drugs Controller General of India (DCGI) for the launch of their ZyCoV-D vaccine for 12 years and above, sources said .
Read More
Zydus Cadila likely to seek emergency authorisation for ZyCoV-D COVID-19 v
Updated : 4 years, 11 months ago IST
New Delhi [India], June 18 (ANI): Pharmaceutical major Zydus Cadila has told the Centre that it could apply for emergency use authorisation (EUA) for ZyCoV-D vaccine in the next seven-eight days.
Read More
Zydus Cadila gets DCGI nod for Phase-3 clinical trials for Covid-19 vaccin
Updated : 5 years, 4 months ago IST
New Delhi [India], January 4 (ANI): The drug regulatory body Drugs Controller General of India (DCGI) has approved Ahmedabad based drug firm Zydus Cadila to initiate Phase III clinical trials of its Covid-19 vaccine ZyCoV-D.
Read More
PM Modi concludes Zydus Biotech Park visit, next stop Bharat Biotech facil
Updated : 5 years, 5 months ago IST
Ahmedabad (Gujarat) [India], November 28 (ANI): Prime Minister Narendra Modi on Saturday concluded his visit to Zydus Biotech Park in Ahmedabad after reviewing the development of COVID-19 vaccine candidate ZyCOV-D.
Read More
Zydus begins human trials for potential COVID-19 vaccine
Updated : 5 years, 10 months ago IST
Ahmedabad (Gujarat) [India], July 15 (ANI): Pharmaceutical major Zydus on Wednesday started human clinical trials of its plasmid DNA vaccine ZyCoV-D -- a potential COVID-19 vaccine.
Read More
Zydus' vaccine for COVID-19 completes pre-clinical development, to initiat
Updated : 5 years, 10 months ago IST
Ahmedabad (Gujarat) [India], July 3 (ANI): Healthcare major Zydus Cadila said on Friday its plasmid DNA vaccine candidate for COVID-19 (ZyCoV-D) developed indigenously at its vaccine technology centre here has successfully completed the pre-clinical phase.
Read More